Development of diagnostic microsphere-based immunoassays for Heartland virus.

Diagnosis Heartland virus Immunoglobulin G Immunoglobulin M MIA Microsphere immunoassay

Journal

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
ISSN: 1873-5967
Titre abrégé: J Clin Virol
Pays: Netherlands
ID NLM: 9815671

Informations de publication

Date de publication:
01 2021
Historique:
received: 05 08 2020
accepted: 11 11 2020
pubmed: 29 11 2020
medline: 18 9 2021
entrez: 28 11 2020
Statut: ppublish

Résumé

Heartland virus (HRTV), a recently reclassified member of the genus Bandavirus, family Phenuiviridae, was first isolated in 2009 from a Missouri farmer exhibiting leukopenia and thrombocytopenia with suspected ehrlichiosis. Since then, more HRTV cases have been diagnosed, and firstline laboratory diagnostic assays are needed to identify future infections Objectives. We sought to develop rapid and reliable IgM and IgG microsphere immunoassays (MIAs) to test sera of patients suspected of having HRTV infection, and to distinguish between recent and past infections. Heartland virus antigen was captured by an anti-HRTV monoclonal antibody covalently bound to microspheres. Antibodies in human sera from confirmed HRTV-positive and negative cases were reacted with the microsphere complexes and detected using a BioPlex® 200 instrument. Assay cutoffs were determined by receiver operator characteristic analysis of the normalized test output values, equivocal zones for each assay were defined, and sensitivities, specificities, accuracies, and imprecision values were calculated. Sensitivities, specificities and accuracies of the IgM and IgG MIAs were all >95 %. Both tests were precise within and between assay plates, and cross-reactivity with other arboviruses was not observed. HRTV IgM and IgG MIAs are accurate and rapid first-line methods to serologically identify recent and past HRTV infections.

Sections du résumé

BACKGROUND
Heartland virus (HRTV), a recently reclassified member of the genus Bandavirus, family Phenuiviridae, was first isolated in 2009 from a Missouri farmer exhibiting leukopenia and thrombocytopenia with suspected ehrlichiosis. Since then, more HRTV cases have been diagnosed, and firstline laboratory diagnostic assays are needed to identify future infections Objectives. We sought to develop rapid and reliable IgM and IgG microsphere immunoassays (MIAs) to test sera of patients suspected of having HRTV infection, and to distinguish between recent and past infections.
STUDY DESIGN
Heartland virus antigen was captured by an anti-HRTV monoclonal antibody covalently bound to microspheres. Antibodies in human sera from confirmed HRTV-positive and negative cases were reacted with the microsphere complexes and detected using a BioPlex® 200 instrument. Assay cutoffs were determined by receiver operator characteristic analysis of the normalized test output values, equivocal zones for each assay were defined, and sensitivities, specificities, accuracies, and imprecision values were calculated.
RESULTS
Sensitivities, specificities and accuracies of the IgM and IgG MIAs were all >95 %. Both tests were precise within and between assay plates, and cross-reactivity with other arboviruses was not observed.
CONCLUSIONS
HRTV IgM and IgG MIAs are accurate and rapid first-line methods to serologically identify recent and past HRTV infections.

Identifiants

pubmed: 33248359
pii: S1386-6532(20)30435-2
doi: 10.1016/j.jcv.2020.104693
pii:
doi:

Substances chimiques

Antibodies, Viral 0
Antigens, Viral 0
Immunoglobulin M 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

104693

Informations de copyright

Published by Elsevier B.V.

Auteurs

Alison Jane Basile (AJ)

Division of Vector Borne Diseases, Centers for Disease Control and Prevention, 3156 Rampart Rd, Fort Collins, CO, 80521, United States. Electronic address: ajj1@cdc.gov.

Kalanthe Horiuchi (K)

Division of Vector Borne Diseases, Centers for Disease Control and Prevention, 3156 Rampart Rd, Fort Collins, CO, 80521, United States.

Christin H Goodman (CH)

Division of Vector Borne Diseases, Centers for Disease Control and Prevention, 3156 Rampart Rd, Fort Collins, CO, 80521, United States.

Olga Kosoy (O)

Division of Vector Borne Diseases, Centers for Disease Control and Prevention, 3156 Rampart Rd, Fort Collins, CO, 80521, United States.

Amanda J Panella (AJ)

Division of Vector Borne Diseases, Centers for Disease Control and Prevention, 3156 Rampart Rd, Fort Collins, CO, 80521, United States.

Jason O Velez (JO)

Division of Vector Borne Diseases, Centers for Disease Control and Prevention, 3156 Rampart Rd, Fort Collins, CO, 80521, United States.

Daniel M Pastula (DM)

Division of Vector Borne Diseases, Centers for Disease Control and Prevention, 3156 Rampart Rd, Fort Collins, CO, 80521, United States.

Aaron C Brault (AC)

Division of Vector Borne Diseases, Centers for Disease Control and Prevention, 3156 Rampart Rd, Fort Collins, CO, 80521, United States.

J Erin Staples (JE)

Division of Vector Borne Diseases, Centers for Disease Control and Prevention, 3156 Rampart Rd, Fort Collins, CO, 80521, United States.

Amanda E Calvert (AE)

Division of Vector Borne Diseases, Centers for Disease Control and Prevention, 3156 Rampart Rd, Fort Collins, CO, 80521, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH